Long-term LDL-C lowering and treatment persistence with inclisiran: 3-year follow-up from the German Inclisiran Network. (PubMed, Clin Res Cardiol) - Sep 29, 2026 - "In a heterogeneous real-world population, inclisiran achieved significant LDL-C reductions but with marked inter- and intraindividual variability. A notable proportion of patients discontinued therapy, highlighting the importance of individualized treatment strategies."
Journal
|
|
Andrea Bässler; Anja Vogt; David Sinning; Elisabeth Steinhagen-Thiessen; Franz Haertel; Friederike Schumann; Jens Arndt Geiling; Juliane Mensch; Ksenija Stach; Oliver Weingärtner; P Christian Schulze; Paulina Stuerzebecher; Ulf Landmesser; Ulrich Laufs; Ulrike Schatz; Umidakhon Makhmudova; Ursula Kassner; Uta Kästner
|